PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 21.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,000 | -20.0% | 5,150 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -99.6% | 5,150 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $1,417,000 | -39.5% | 1,200,680 | 0.0% | 0.11% | -40.4% |
| Q2 2015 | $2,341,000 | +9.5% | 1,200,680 | 0.0% | 0.18% | +2.9% |
| Q1 2015 | $2,137,000 | -3.3% | 1,200,680 | 0.0% | 0.17% | -10.8% |
| Q4 2014 | $2,209,000 | -24.0% | 1,200,680 | 0.0% | 0.19% | -3.0% |
| Q3 2014 | $2,906,000 | -4.8% | 1,200,680 | +43.6% | 0.20% | -18.0% |
| Q2 2014 | $3,052,000 | -20.3% | 836,078 | 0.0% | 0.24% | -22.3% |
| Q1 2014 | $3,829,000 | -5.5% | 836,078 | -19.7% | 0.31% | -11.8% |
| Q4 2013 | $4,050,000 | -14.1% | 1,041,078 | 0.0% | 0.36% | -17.6% |
| Q3 2013 | $4,716,000 | -12.0% | 1,041,078 | -4.6% | 0.43% | -5.1% |
| Q2 2013 | $5,357,000 | – | 1,091,078 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ion Asset Management Ltd. | 4,035,008 | $1,796,000 | 0.76% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 4,779,800 | $2,127,000 | 0.04% |
| ANGELO GORDON & CO., L.P. | 1,057,068 | $470,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 4,000,000 | $1,780,000,000 | 0.03% |
| Nine Chapters Capital Management LLC | 21,300 | $9,000 | 0.02% |
| FEDERATED HERMES, INC. | 2,143,431 | $954,000 | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 40,000 | $18,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $135,000 | 0.00% |
| WEDBUSH SECURITIES INC | 18,000 | $8,000 | 0.00% |
| Spark Investment Management LLC | 23,800 | $10,000 | 0.00% |